Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Elenko

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology in Drug Development|November 15, 2021
A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium-Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic DiseasesMichael C Chen, Christopher C Korth, Mark D Harnett, et al.
Molecular Pharmacology|June 20, 2003
Spatial regulation of Galphai protein signaling in clathrin-coated membrane microdomains containing GAIPEric Elenko, Thierry Fischer, Ingrid Niesman, et al.
ERJ Open Research|March 18, 2026
A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adultsToby M Maher, Michael C Chen, Chris C Korth, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled TrialToby M Maher, Mark J Hamblin, Won-Ii Choi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology in Drug Development|November 15, 2021
A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium-Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic DiseasesMichael C Chen, Christopher C Korth, Mark D Harnett, et al.
Molecular Pharmacology|June 20, 2003
Spatial regulation of Galphai protein signaling in clathrin-coated membrane microdomains containing GAIPEric Elenko, Thierry Fischer, Ingrid Niesman, et al.
ERJ Open Research|March 18, 2026
A phase 1 pharmacokinetics study of deupirfenidone (LYT-100) in healthy older adultsToby M Maher, Michael C Chen, Chris C Korth, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled TrialToby M Maher, Mark J Hamblin, Won-Ii Choi, et al.
Pageof 1